Clinical Trials in Ohio

Showing 19041-19060 of 20,938 trials

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

NCT00005035

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of oxaliplatin in treating patients who have advanced head and neck cancer.

Head and Neck Cancer

Ohio State University Comprehensive Cancer CenterStarted Dec 1999

Chicago, Illinois, United States • Chicago, Illinois, United States • Decatur, Illinois, United States +8 more locations

COMPLETEDPhase 132 miles

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

NCT00006000

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. SU5416 may stop the growth of solid tumors by stopping blood flow to the tumor. Combining SU5416 with chemotherapy may kill more cancer cells. PURPOSE: Phase I trial to study the effectiveness of SU5416 plus irinotecan and cisplatin in treating patients who have advanced solid tumors.

Unspecified Adult Solid Tumor, Protocol Specific

Ohio State University Comprehensive Cancer CenterStarted Aug 2000

Columbus, Ohio, United States

Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

SU5416, Irinotecan, and Cisplatin in Treating Patients With Advanced Solid Tumors

Find Trials by Condition in Ohio

S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium

A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer

PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors

FR901228 in Treating Patients With Hematologic Cancer

S9900: Surgery With or Without Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer

Interleukin-2 and Stem Cell Factor in Treating Patients With AIDS or AIDS-Related Cancer

FREEDOM DR: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor or as Monotherapy for the Treatment of Pulmonary Arterial Hypertension (PAH)

Open Label Continuation Study in Moderate to Severe Psoriasis

Therapy Optimization in Multiple Sclerosis (MS)

Trial of Linaclotide in Patients With Chronic Constipation

Optimize RV Selective Site Pacing Clinical Trial

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

A Phase 3 Study of Siltuximab or Placebo in Combination With Velcade and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Radiation Therapy and Chemotherapy in Treating Children With CNS Relapse From Acute Lymphoblastic Leukemia

Efficacy and Safety Study for Subjects With Mild-to-Moderate Alzheimer's Disease

Computer-Based Survey and Communication Aid in Improving Physician-Patient Communication and Treatment Decision Making in Patients With Metastatic Cancer

Phase II Trial of Capecitabine With Fulvestrant for Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer

Elitek (Rasburicase) Immuno-Monitoring Study